# Implementing the SAFE@home digital platform for blood pressure home monitoring for patients with (a risk of) hypertensive disorders of pregnancy: A barrier and facilitator analysis among obstetric healthcare professionals

**Authors:** Shinta L Moes, Martine Depmann, Kvamme Ingelin, Elles In ’T Anker, Jacques Dirken, Leonoor Van Eerden, Arie Franx, Roel De Heus, Sanne J Gordijn, Steven Koenen, Maarten MH Lahr, Titia A Lely, Flip Van Der Made, Lindy Santegoets, Marc Spaanderman, Ewoud Schuit, Mireille N Bekker

PMC · DOI: 10.1177/20552076251376518 · Digital Health · 2025-10-23

## TL;DR

This study examines how well healthcare professionals in the Netherlands adopted a digital platform for home blood pressure monitoring in high-risk pregnancies, finding high acceptance despite some barriers.

## Contribution

The study provides insights into the implementation barriers and facilitators of a telemonitoring platform for hypertensive disorders of pregnancy among obstetric healthcare professionals.

## Key findings

- SAFE@home was well-received with high adoption rates and perceived benefits for patient outcomes.
- Confidence in using the platform increased significantly over time.
- Time constraints and uncertainty about usage were the main barriers to implementation.

## Abstract

Hypertensive disorders of pregnancy complicate at least 10% of pregnancies, and are associated with fetomaternal morbidity and mortality. Traditional management is resource-intensive. Remote monitoring offers a safe and patient friendly alternative to managing hypertensive disorders. However, scaling telemonitoring requires understanding of implementation facilitators and barriers. This study explores the implementation of SAFE@home, a platform for monitoring blood pressure and symptoms, among obstetric healthcare professionals (OHPs).

An implementation study was conducted across 11 Dutch hospitals from November 2020 to December 2023, evaluating implementation of a home-monitoring platform for pregnant women with a high risk of or with established hypertensive disorders. Implementation outcomes were evaluated using Proctor's taxonomy, Normalization Measurement Development and Measurement Instrument for Determinants of Innovations questionnaires, platform, and electronic health records data. OHPs received questionnaires at the start of implementation (T = 1) and between 9 and 18 months (T = 2). Median and proportion of scores were analyzed.

Of 133 OHPs, 83 (62.4%) and 101 (75.9%) responded to T = 1 and T = 2, respectively. SAFE@home was well-received, with a median score of 4/5 on questionnaires at both time points. Adoption was 100%, and OHPs were receptive to using the platform (95% at T = 1; 92% at T = 2). Confidence in using SAFE@home was 48% (T = 1) and 85% (T = 2); 86% believed it improved outcomes and 82% found work integration easy. Overall, 91% anticipated SAFE@home to become routine. Barriers included time constraints (46%) and uncertainty about usage (20%).

SAFE@home was successfully implemented, with high acceptance and sustainability potential. While time constraints and initial uncertainty were barriers, most OHPs believed telemonitoring could improve care for high-risk pregnancies.

## Full-text entities

- **Diseases:** Hypertensive disorders of pregnancy (MESH:D046110), hypertensive disorders (MESH:D006973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12559661/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12559661/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12559661/full.md

---
Source: https://tomesphere.com/paper/PMC12559661